Monthly Archive for: ‘November, 2018’
Last year, Bayer was awarded more than $25 million (plus interest and indemnity costs) against Generic Health in the first Federal Court award of damages for pharmaceutical patent infringement. In the appeal by Generic Health, the Full Court of the Federal Court allowed Generic Health a 2% discount to the $25 million damages originally awarded. What made the FCFCA give Generic Health such a modest discount?
Remember Naruto, the monkey that took a selfie? Courts in the United States determined that human authorship was a requirement for copyright protection. So, if we can’t award monkey copyright, what about AI?